TrialsgrambetaRCTs are beautiful

TAILORED-AF

2025

Artificial Intelligence for Individualized Treatment of Persistent Atrial Fibrillation: a Randomized Controlled Trial

In 370 patients with drug-refractory persistent atrial fibrillation, AI-guided ablation of electrogram dispersion added to pulmonary vein isolation improved freedom from atrial fibrillation at 12 months compared with pulmonary vein isolation alone.

Result

Freedom from documented AF, with or without antiarrhythmic drugs, at 12 months after a single ablation procedure
Absolute difference
18 points
NNT
6

Absolute difference and NNT are derived from the event rates.

Also reported: For superiority); no significant difference in freedom from any atrial arrhythmia after one procedure; safety composite did not differ; procedure and ablation times twice as long in the tailored arm.

Original publication
Subtopic
Rhythm & devices
Design
Multicentre double-blind superiority RCT
Relevance
Important: one of several pillars.
Source
Deisenhofer I, et al. Nat Med. 2025;31(4):1286-1293.doi 10.1038/s41591-025-03517-w

Discussion & critique

The first randomised trial in which an AI-identified ablation target beat pulmonary vein isolation alone in persistent AF. The gain was specific to AF: freedom from any atrial arrhythmia was not different, because tailored ablation can leave organised atrial tachycardias that need a further procedure, and the procedures took twice as long. Follow-up was 12 months after a single procedure.